Cacciatore L, Cerio R, Ciarimboli M, et al. The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study.
Drugs Exp Clin Res. 1991;17:225 - 235.
Cherchi A, Lai C, Angelino F, et al. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
Int J Clin Pharmacol Ther Toxicol. 1985;23:569 - 572.
Bartels GL, Remme WJ, Pillay M, et al. Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.
Am J Cardiol. 1994;74:125 - 130.
Bartels GL, Remme WJ, den Hartog FR, et al. Additional anti-ischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.
Cardiovasc Drugs Ther.
1995;9:749 - 753.
Lagioia R, Scrutinio D, Mangini SG, et al. Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
Int J Cardiol. 1992;34:167 - 172.
Bartels GL, Remme WJ, Holwerda KJ, et al. Anti-ischaemic efficacy of L-propionylcarnitine - a promising novel metabolic approach to ischaemia?
Eur Heart J.
1996;17:414 - 420.
Bednarz B, Wolk R, Chamiec T, et al. Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris.
Int J Cardiol. 2000;75:205 - 210.
Kamikawa T, Kobayashi A, Yamashita T, et al. Effects of coenzyme Q
10
on exercise tolerance in chronic stable angina pectoris.
Am J Cardiol.
1985;56:247 - 251.
Ernst E. Chelation therapy for coronary heart disease: An overview of all clinical investigations.
Am Heart J. 2000;140:4 - 5.
Pizzulli L, Hagendorff A, Zirbes M, et al. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function.
Am J Cardiol. 1997;79:28 - 33.
Ardissino D, Merlini PA, Savonitto S, et al. Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris.
J Am Coll Cardiol.
1997;29:941 - 947.
Iversen H. N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses.
Clin Pharmacol Ther.
1992;52:125 - 33.
Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta-carotene on the incidence of angina pectoris.
JAMA.
1996;275:693 - 698.
Maxwell AJ, Zapien MP, Pearce GL, et al. Randomized trial of a medical food for the dietary management of chronic, stable angina.
J Am Coll Cardiol. 2002;39:37 - 45.
Khogali SE, Pringle SD, Weryk BV, et al. Is glutamine beneficial in ischemic heart disease?
Nutrition.
2002;18:123 - 126.
Bharani A, Ganguli A, Mathur LK, et al. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
Indian Heart J.
2002;54:170-175.
Shechter M, Bairey Merz CN, Stuehlinger HG, et al. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease.
Am J Cardiol. 2003;91:517 521.
Shechter M, Sharir M, Labrador MJ, et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease.
Circulation. 2000;102:2353 - 2358.
Antani J, Kulkarni R, Antani N. Effect of Abana on ventricular function in ischaemic heart disease.
Japanese Heart Journal. 1990;31:829 - 835.
Anderson TJ, Hubacek J, Wyse DG, et al. Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy.
J Am Coll Cardiol. 2003;41:420 425.
Knudtson ML, Wyse DG, Galbraith PD, et al. Chelation therapy for ischemic heart disease: a randomized controlled trial.
JAMA. 2002;287:481 - 486.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.